Concord Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
18,466
+1,162
+7% +$104K 0.2% 106
2025
Q4
$1.37M Buy
17,304
+792
+5% +$62.1K 0.18% 111
2025
Q3
$1.32M Buy
16,512
+2,008
+14% +$171K 0.18% 108
2025
Q2
$1.32M Sell
14,504
-1,681
-10% -$153K 0.19% 113
2025
Q1
$1.52M Sell
16,185
-1,629
-9% -$146K 0.25% 94
2024
Q4
$1.62M Buy
17,814
+6,196
+53% +$591K 0.27% 80
2024
Q3
$1.21M Buy
11,618
+872
+8% +$88.9K 0.2% 87
2024
Q2
$1.04M Buy
10,746
+3,650
+51% +$337K 0.18% 98
2024
Q1
$639K Buy
7,096
+1,163
+20% +$98.5K 0.12% 126
2023
Q4
$473K Buy
5,933
+5,754
+3,215% +$433K 0.09% 133
2023
Q3
$12.7K Sell
179
-133
-43% -$9.94K ﹤0.01% 581
2023
Q2
$24K Buy
312
+107
+52% +$8.28K 0.01% 476
2023
Q1
$15.4K Sell
205
-493
-71% -$36.7K ﹤0.01% 531
2022
Q4
$55K Buy
+698
New +$52.3K 0.02% 363
2022
Q3
Sell
-2,609
Closed -$209K 324
2022
Q2
$209K Sell
2,609
-101
-4% -$7.9K 0.06% 157
2022
Q1
$205K Buy
2,710
+151
+6% +$12K 0.05% 177
2021
Q4
$218K Buy
2,559
+1,606
+169% +$125K 0.05% 174
2021
Q3
$72K Sell
953
-1,323
-58% -$105K 0.03% 168
2021
Q2
$185K Sell
2,276
-136
-6% -$11.1K 0.05% 147
2021
Q1
$190K Buy
2,412
+2,145
+803% +$168K 0.06% 137
2020
Q4
$23K Buy
+267
New +$22.1K 0.02% 292

Other funds holding CL

Concord Wealth Partners's CL Position: Q1 2026 in Review

Concord Wealth Partners increased its Colgate-Palmolive (CL) stake by 6.7% in Q1 2026, buying an estimated $104K and bringing the position to 18,466 shares worth $1.57M. The position accounts for 0.2% of the portfolio, ranked #106.

Concord Wealth Partners first reported a position in CL in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.62M in Q4 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Concord Wealth Partners held 18,466 shares of Colgate-Palmolive worth $1.57M as of Q1 2026.
  • Concord Wealth Partners bought 1,162 Colgate-Palmolive shares in Q1 2026, an estimated $104K.
  • Colgate-Palmolive made up 0.2% of Concord Wealth Partners's portfolio in Q1 2026, its #106 holding.
  • Concord Wealth Partners first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 21 quarters since.
  • Concord Wealth Partners's Colgate-Palmolive position peaked at $1.62M in Q4 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Concord Wealth Partners's 13F filing for Q1 2026, filed 1 May 2026.